• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Gilead Illinois


<



















how did we lose our home state of IL Medicaid to Gilead? Mav getting denied. Also heard CA has exclusive contracts for Medicaid. Wtf


Uh, Express scripts told y’all in August 2018, you’re off formulary. Gileads Epclusa, Harvoni and Vosevi along with Merck’s Zepatier are preferred therapies.Abbvies benefit managers are horrible. Old news if you’re referring in Expess.
 




Let’s face it, providers don’t like Mav and you thought low balling the price would lock out Gilead long term. They called your bluff and now watch out. You put lipstick on a pig, Mav is still a pig